Muņoz, Raquel <br/><br/>
In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Mar 2013 
 - 541-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0851 
<br/><br/><label>Standard No.: </label>10.1007/s00262-012-1357-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antigens, CD--immunology<br/>Cell Line<br/>Cell Line, Tumor<br/>Endoglin<br/>Immunotoxins--pharmacology<br/>Melanoma, Experimental--blood supply<br/>Mice<br/>Mice, Inbred C57BL<br/>Neovascularization, Pathologic--drug therapy<br/>Plant Proteins--administration & dosage<br/>Receptors, Cell Surface--immunology<br/>Ribosome Inactivating Proteins--administration & dosage